A Research Study to Evaluate the Safety and Effectiveness of MK0686 for the Treatment of Postherpetic Neuralgia (Also Known as PHN or Post Shingles Pain) (0686-005)
Condition: Neuralgia, PostherpeticIntervention: Drug: MK0686Sponsor: Merck Sharp & Dohme Corp.Terminated - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2006 Category: Research Source Type: clinical trials
A Research Study to Evaluate the Safety and Effectiveness of MK0686 for the Treatment of Postherpetic Neuralgia (Also Known as PHN or Post Shingles Pain) (0686-005)
Condition: Neuralgia, PostherpeticIntervention: Drug: MK0686Sponsor: Merck Sharp & Dohme Corp.Terminated - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2006 Category: Research Source Type: clinical trials
A Research Study to Evaluate the Safety and Effectiveness of MK0686 for the Treatment of Postherpetic Neuralgia (Also Known as PHN or Post Shingles Pain) (0686-005)
Condition: Neuralgia, PostherpeticIntervention: Drug: MK0686Sponsor: Merck Sharp & Dohme Corp.Terminated - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2006 Category: Research Source Type: clinical trials
A Research Study to Evaluate the Safety and Effectiveness of MK0686 for the Treatment of Postherpetic Neuralgia (Also Known as PHN or Post Shingles Pain) (0686-005)
Condition: Neuralgia, PostherpeticIntervention: Drug: MK0686Sponsor: Merck Sharp & Dohme Corp.Terminated - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2006 Category: Research Source Type: clinical trials